clinical updates on alk inhibitor treatment strategies for nsclc
Published 5 years ago • 182 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
3:53
how to maximize clinical benefits for patients with alk-positive non-small cell lung cancer
-
2:10
molecularly-guided treatment of advanced nsclc: alk inhibitor sequencing
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
10:43
updates in alk nsclc
-
2:00
updated data from phase 2 study of alectinib in alk–positive non–small–cell lung cancer
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
2:21
current treatment landscape for alk-positive nsclc
-
1:42
next-generation alk inhibitors: treatment sequencing and resistance
-
1:25
updates and unmet needs in alk-mutated lung cancer
-
22:10
first and second generation alk inhibitors for the treatment of lung cancer
-
1:24
choosing the best alk inhibitor for lung cancer
-
1:14
treatment sequecing strategies in advanced nsclc
-
1:05
dr. aggarwal on emerging treatment approaches in alk nsclc
-
6:36
sequencing strategies for alk-targeted therapy
-
8:17
third-generation alk inhibitors for nsclc
-
5:44
updates in alk lung cancer: glass, alex, alta-1l and crown
-
1:28
advances in alk-mutant nsclc
-
1:01
targeting alk rearrangements in non-small cell lung cancer
-
8:04
treating with alk inhibitors in nsclc